| Targeting cell-cycle machinery in cancer JM Suski, M Braun, V Strmiska, P Sicinski Cancer cell 39 (6), 759-778, 2021 | 384 | 2021 |
| MicroRNAs in regulation of triple-negative breast cancer progression D Piasecka, M Braun, R Kordek, R Sadej, H Romanska Journal of cancer research and clinical oncology 144, 1401-1411, 2018 | 198 | 2018 |
| Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL L Hamadeh, A Enshaei, C Schwab, CN Alonso, A Attarbaschi, G Barbany, ... Blood advances 3 (2), 148-157, 2019 | 72 | 2019 |
| MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients D Jesionek-Kupnicka, M Braun, B Trąbska-Kluch, J Czech, M Szybka, ... Archives of Medical Science 15 (2), 504, 2019 | 60 | 2019 |
| CDC7-independent G1/S transition revealed by targeted protein degradation JM Suski, N Ratnayeke, M Braun, T Zhang, V Strmiska, W Michowski, ... Nature 605 (7909), 357-365, 2022 | 59 | 2022 |
| Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia M Braun, A Pastorczak, W Fendler, J Madzio, B Tomasik, J Taha, ... Leukemia & lymphoma 58 (5), 1162-1171, 2017 | 57 | 2017 |
| Effectiveness and safety of immunotherapy in NSCLC patients with ECOG PS score≥ 2–Systematic review and meta-analysis B Tomasik, M Bieńkowski, M Braun, S Popat, R Dziadziuszko Lung Cancer 158, 97-106, 2021 | 52 | 2021 |
| Cadmium and breast cancer–Current state and research gaps in the underlying mechanisms K Tarhonska, M Lesicka, B Janasik, J Roszak, E Reszka, M Braun, ... Toxicology Letters 361, 29-42, 2022 | 48 | 2022 |
| FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors–implications for therapy of luminal breast cancer D Piasecka, M Braun, K Kitowska, K Mieczkowski, R Kordek, R Sadej, ... Journal of Experimental & Clinical Cancer Research 38, 1-12, 2019 | 45 | 2019 |
| Intratumor heterogeneity and tissue distribution of KRAS mutation in non-small cell lung cancer: implications for detection of mutated KRAS oncogene in exhaled breath condensate J Kordiak, J Szemraj, I Grabska-Kobylecka, P Bialasiewicz, M Braun, ... Journal of Cancer Research and Clinical Oncology 145, 241-251, 2019 | 41 | 2019 |
| Prognostic significance of IKZF1 deletions and IKZF1plus profile in children with B‐cell precursor acute lymphoblastic leukemia treated according to the ALL‐IC … M Braun, A Pastorczak, Ł Sędek, J Taha, J Madzio, I Jatczak‐Pawlik, ... Hematological Oncology 40 (3), 430-441, 2022 | 20 | 2022 |
| A peptide antagonist of F11R/JAM-A reduces plaque formation and prolongs survival in an animal model of atherosclerosis A Babinska, CC Clement, T Przygodzki, M Talar, Y Li, M Braun, J Wzorek, ... Atherosclerosis 284, 92-101, 2019 | 19 | 2019 |
| Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions A Pastorczak, L Sedek, M Braun, J Madzio, A Sonsala, M Twardoch, ... Oncotarget 9 (40), 25971, 2018 | 19 | 2018 |
| Efficacy and safety of B-cell receptor signaling pathway inhibitors in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis of randomized … A Puła, K Stawiski, M Braun, E Iskierka-Jażdżewska, T Robak Leukemia & lymphoma 59 (5), 1084-1094, 2018 | 19 | 2018 |
| Time-dependent interactions of blood platelets and cancer cells, accompanied by extramedullary hematopoiesis, lead to increased platelet activation and reactivity in a mouse … H Kassassir, K Karolczak, KM Siewiera, DW Wojkowska, M Braun, ... Aging (Albany NY) 12 (6), 5091, 2020 | 18 | 2020 |
| The expression of the slit–robo family in adult patients with acute myeloid leukemia A Gołos, D Jesionek-Kupnicka, L Gil, M Braun, M Komarnicki, T Robak, ... Archivum immunologiae et therapiae experimentalis 67, 109-123, 2019 | 18 | 2019 |
| Pure hepatocellular carcinoma originates from an ectopic liver nodule located in the pancreas M Braun, W Kuncman, L Teresiński, P Kupnicki, D Jesionek-Kupnicka, ... Contemporary Oncology/Współczesna Onkologia 21 (4), 311-314, 2018 | 18 | 2018 |
| FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer K Mieczkowski, K Kitowska, M Braun, B Galikowska‐Bogut, ... Molecular Oncology 16 (15), 2823-2842, 2022 | 17 | 2022 |
| Upregulation of HIF1-α via an NF-κB/COX2 pathway confers proliferative dominance of HER2-negative ductal carcinoma in situ cells in response to inflammatory stimuli D Piasecka, M Braun, M Mieszkowska, L Kowalczyk, J Kopczynski, ... Neoplasia 22 (11), 576-589, 2020 | 16 | 2020 |
| Association of ACTN3 Polymorphism with Body Somatotype and Cardiorespiratory Fitness in Young Healthy Adults N Potocka, B Penar-Zadarko, M Skrzypa, M Braun, ... International Journal of Environmental Research and Public Health 16 (9), 1489, 2019 | 15 | 2019 |
Dominika PiaseckaGdański Uniwersytet MedycznyVerified email at gumed.edu.pl